606 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 13 | next »
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
GIPC2GIPC PDZ domain containing family member 2
Kidney Renal Clear Cell Carcinoma (TCGA): 6.88e-14
Kidney Renal Clear Cell Carcinoma (validation): 7.39e-7
Colon Adenocarcinoma (TCGA): 1.71e-6
SORT1Sortilin 1
Colon Adenocarcinoma (TCGA): 9.78e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 9.17e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.80e-4
BCL10BCL10 immune signaling adaptor
Kidney Renal Clear Cell Carcinoma (TCGA): 4.31e-10
Colon Adenocarcinoma (TCGA): 1.19e-5
Liver Hepatocellular Carcinoma (TCGA): 4.64e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.49e-4
ARFIP1ADP ribosylation factor interacting protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.23e-9
Colon Adenocarcinoma (TCGA): 1.74e-5
Kidney Renal Clear Cell Carcinoma (validation): 6.91e-4
USP53Ubiquitin specific peptidase 53
Kidney Renal Clear Cell Carcinoma (TCGA): 5.00e-6
Colon Adenocarcinoma (TCGA): 2.41e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.12e-4
SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor
Kidney Renal Clear Cell Carcinoma (TCGA): 1.56e-5
Colon Adenocarcinoma (TCGA): 3.68e-5
Liver Hepatocellular Carcinoma (TCGA): 6.14e-4
Liver Hepatocellular Carcinoma (validation): 7.34e-4
Lung Adenocarcinoma (validation): 9.18e-4
HERC3HECT and RLD domain containing E3 ubiquitin protein ligase 3
Kidney Renal Clear Cell Carcinoma (TCGA): 5.05e-8
Kidney Renal Clear Cell Carcinoma (validation): 7.80e-6
Colon Adenocarcinoma (TCGA): 4.53e-5
DPP7Dipeptidyl peptidase 7
Colon Adenocarcinoma (TCGA): 4.71e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 9.25e-5
Colon Adenocarcinoma (validation): 2.34e-4
ZNF207Zinc finger protein 207
Kidney Renal Clear Cell Carcinoma (TCGA): 7.11e-7
Liver Hepatocellular Carcinoma (TCGA): 1.25e-5
Kidney Chromophobe (TCGA): 3.48e-5
Colon Adenocarcinoma (TCGA): 6.06e-5
Liver Hepatocellular Carcinoma (validation): 1.25e-4
Lung Adenocarcinoma (TCGA): 3.63e-4
TAF13TATA-box binding protein associated factor 13
Kidney Renal Clear Cell Carcinoma (TCGA): 8.73e-6
Kidney Renal Clear Cell Carcinoma (validation): 9.51e-6
Glioblastoma Multiforme (validation): 4.97e-5
Colon Adenocarcinoma (TCGA): 6.10e-5
NUDT1Nudix hydrolase 1
Liver Hepatocellular Carcinoma (validation): 1.19e-8
Kidney Renal Clear Cell Carcinoma (validation): 7.31e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.26e-5
Colon Adenocarcinoma (TCGA): 6.81e-5
Liver Hepatocellular Carcinoma (TCGA): 2.45e-4
Glioblastoma Multiforme (TCGA): 4.43e-4
Lung Adenocarcinoma (validation): 6.07e-4
Lung Adenocarcinoma (TCGA): 6.60e-4
SFPQSplicing factor proline and glutamine rich
Liver Hepatocellular Carcinoma (TCGA): 5.90e-11
Colon Adenocarcinoma (TCGA): 7.64e-5
Liver Hepatocellular Carcinoma (validation): 1.84e-4
Breast Invasive Carcinoma (validation): 2.59e-4
Lung Adenocarcinoma (TCGA): 2.71e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.92e-4
UBE2D2Ubiquitin conjugating enzyme E2 D2
Liver Hepatocellular Carcinoma (TCGA): 1.37e-6
Breast Invasive Carcinoma (validation): 2.44e-5
Colon Adenocarcinoma (TCGA): 8.30e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.47e-4
Liver Hepatocellular Carcinoma (validation): 3.90e-4
PSMB5Proteasome 20S subunit beta 5
Liver Hepatocellular Carcinoma (TCGA): 1.30e-7
Liver Hepatocellular Carcinoma (validation): 3.24e-6
Head and Neck Squamous Cell Carcinoma (TCGA): 3.12e-5
Colon Adenocarcinoma (TCGA): 1.31e-4
Lung Adenocarcinoma (validation): 2.56e-4
Bladder Urothelial Carcinoma (TCGA): 2.78e-4
MARVELD1MARVEL domain containing 1
Lung Adenocarcinoma (TCGA): 5.30e-6
Colon Adenocarcinoma (TCGA): 1.50e-4
Ovary Serous Cystadenocarcinoma (validation): 1.70e-4
Glioblastoma Multiforme (validation): 6.49e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.74e-4
LEPROTL1Leptin receptor overlapping transcript like 1
Kidney Renal Clear Cell Carcinoma (TCGA): 3.92e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.40e-4
Colon Adenocarcinoma (TCGA): 1.52e-4
Liver Hepatocellular Carcinoma (TCGA): 1.79e-4
AMD1Adenosylmethionine decarboxylase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.62e-12
Liver Hepatocellular Carcinoma (TCGA): 2.73e-6
Liver Hepatocellular Carcinoma (validation): 6.70e-6
Colon Adenocarcinoma (TCGA): 1.52e-4
Breast Invasive Carcinoma (TCGA): 3.58e-4
LYPD6LY6/PLAUR domain containing 6
Bladder Urothelial Carcinoma (TCGA): 1.32e-4
Colon Adenocarcinoma (TCGA): 2.48e-4
Colon Adenocarcinoma (validation): 5.58e-4
ATP8B1ATPase phospholipid transporting 8B1
Kidney Renal Clear Cell Carcinoma (validation): 3.74e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 2.43e-4
Colon Adenocarcinoma (TCGA): 3.38e-4
MAGI3Membrane associated guanylate kinase, WW and PDZ domain containing 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.77e-7
Kidney Renal Clear Cell Carcinoma (validation): 8.74e-5
Colon Adenocarcinoma (TCGA): 3.52e-4
NUDT9Nudix hydrolase 9
Kidney Renal Clear Cell Carcinoma (TCGA): 9.79e-9
Kidney Renal Clear Cell Carcinoma (validation): 2.30e-4
Colon Adenocarcinoma (TCGA): 3.57e-4
SNX7Sorting nexin 7
Kidney Renal Clear Cell Carcinoma (TCGA): 1.35e-7
Liver Hepatocellular Carcinoma (validation): 2.83e-6
Liver Hepatocellular Carcinoma (TCGA): 6.83e-6
Lung Adenocarcinoma (TCGA): 3.93e-4
Colon Adenocarcinoma (TCGA): 4.06e-4
TXNDC12Thioredoxin domain containing 12
Liver Hepatocellular Carcinoma (TCGA): 6.82e-9
Liver Hepatocellular Carcinoma (validation): 9.38e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.36e-4
Colon Adenocarcinoma (TCGA): 4.28e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 4.97e-4
SRSF3Serine and arginine rich splicing factor 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.00e-8
Liver Hepatocellular Carcinoma (TCGA): 2.27e-6
Colon Adenocarcinoma (TCGA): 4.47e-4
Liver Hepatocellular Carcinoma (validation): 5.15e-4
JPT1Jupiter microtubule associated homolog 1
Liver Hepatocellular Carcinoma (TCGA): 2.53e-9
Kidney Renal Clear Cell Carcinoma (TCGA): 8.31e-8
Kidney Renal Clear Cell Carcinoma (validation): 6.88e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 1.52e-4
Colon Adenocarcinoma (TCGA): 4.97e-4
Bladder Urothelial Carcinoma (TCGA): 9.76e-4
ARMT1Acidic residue methyltransferase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 6.20e-7
Colon Adenocarcinoma (TCGA): 5.14e-4
Colon Adenocarcinoma (validation): 5.86e-4
ARHGAP5Rho GTPase activating protein 5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.85e-9
Colon Adenocarcinoma (validation): 3.54e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.82e-4
Colon Adenocarcinoma (TCGA): 5.53e-4
CNOT6LCCR4-NOT transcription complex subunit 6 like
Kidney Renal Clear Cell Carcinoma (TCGA): 1.61e-8
Kidney Renal Clear Cell Carcinoma (validation): 4.35e-6
Colon Adenocarcinoma (TCGA): 6.02e-4
ETFDHElectron transfer flavoprotein dehydrogenase
Kidney Renal Clear Cell Carcinoma (TCGA): 5.53e-11
Kidney Renal Clear Cell Carcinoma (validation): 5.25e-5
Colon Adenocarcinoma (TCGA): 6.61e-4
FUCA1Alpha-L-fucosidase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 0.00e+0
Bladder Urothelial Carcinoma (TCGA): 2.90e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.68e-5
Glioblastoma Multiforme (validation): 8.21e-5
Glioblastoma Multiforme (TCGA): 1.65e-4
Colon Adenocarcinoma (TCGA): 6.62e-4
AIMP2Aminoacyl tRNA synthetase complex interacting multifunctional protein 2
Kidney Chromophobe (TCGA): 7.35e-5
Breast Invasive Carcinoma (TCGA): 8.20e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 9.92e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 3.74e-4
Lung Adenocarcinoma (validation): 6.73e-4
Colon Adenocarcinoma (TCGA): 6.75e-4
Lung Adenocarcinoma (TCGA): 7.91e-4
EFTUD2Elongation factor Tu GTP binding domain containing 2
Liver Hepatocellular Carcinoma (validation): 9.87e-6
Liver Hepatocellular Carcinoma (TCGA): 1.69e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.52e-5
Colon Adenocarcinoma (TCGA): 6.76e-4
MMAAMetabolism of cobalamin associated A
Kidney Renal Clear Cell Carcinoma (TCGA): 4.22e-11
Liver Hepatocellular Carcinoma (validation): 7.95e-8
Kidney Renal Clear Cell Carcinoma (validation): 8.99e-6
Pancreatic Adenocarcinoma (TCGA): 3.44e-4
Colon Adenocarcinoma (TCGA): 7.03e-4
PTP4A2Protein tyrosine phosphatase 4A2
Liver Hepatocellular Carcinoma (TCGA): 4.67e-7
Liver Hepatocellular Carcinoma (validation): 1.37e-5
Kidney Chromophobe (TCGA): 2.23e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.00e-4
Colon Adenocarcinoma (TCGA): 7.06e-4
CDC42Cell division cycle 42
Kidney Renal Clear Cell Carcinoma (TCGA): 3.72e-9
Liver Hepatocellular Carcinoma (TCGA): 1.69e-5
Liver Hepatocellular Carcinoma (validation): 6.01e-5
Colon Adenocarcinoma (TCGA): 7.07e-4
SMAP1Small ArfGAP 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.69e-5
Liver Hepatocellular Carcinoma (TCGA): 4.15e-5
Liver Hepatocellular Carcinoma (validation): 7.34e-5
Colon Adenocarcinoma (TCGA): 7.10e-4
NUMBLNUMB like endocytic adaptor protein
Kidney Renal Clear Cell Carcinoma (TCGA): 1.27e-9
Kidney Renal Clear Cell Carcinoma (validation): 8.00e-8
Lung Adenocarcinoma (TCGA): 5.01e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.80e-5
Ovary Serous Cystadenocarcinoma (TCGA): 1.80e-4
Colon Adenocarcinoma (TCGA): 7.25e-4
RP9RP9 pre-mRNA splicing factor
Liver Hepatocellular Carcinoma (TCGA): 2.24e-5
Liver Hepatocellular Carcinoma (validation): 3.80e-4
Lung Adenocarcinoma (TCGA): 6.11e-4
Pancreatic Adenocarcinoma (TCGA): 7.14e-4
Colon Adenocarcinoma (TCGA): 8.53e-4
FDFT1Farnesyl-diphosphate farnesyltransferase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 5.49e-9
Glioblastoma Multiforme (validation): 1.39e-4
Kidney Renal Clear Cell Carcinoma (validation): 3.82e-4
Colon Adenocarcinoma (TCGA): 8.56e-4
Pancreatic Adenocarcinoma (TCGA): 8.87e-4
GNAI3G protein subunit alpha i3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.78e-7
Liver Hepatocellular Carcinoma (TCGA): 2.48e-6
Liver Hepatocellular Carcinoma (validation): 1.08e-4
Lung Adenocarcinoma (TCGA): 1.44e-4
Lung Adenocarcinoma (validation): 5.47e-4
Colon Adenocarcinoma (TCGA): 8.72e-4
UBE2KUbiquitin conjugating enzyme E2 K
Kidney Renal Clear Cell Carcinoma (TCGA): 1.66e-6
Kidney Renal Clear Cell Carcinoma (validation): 1.79e-4
Lung Adenocarcinoma (TCGA): 3.28e-4
Liver Hepatocellular Carcinoma (validation): 6.39e-4
Colon Adenocarcinoma (TCGA): 8.80e-4
TNNT1Troponin T1, slow skeletal type
Kidney Renal Clear Cell Carcinoma (TCGA): 1.55e-15
Pancreatic Adenocarcinoma (validation): 5.28e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.21e-5
Liver Hepatocellular Carcinoma (TCGA): 4.72e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.36e-4
Pancreatic Adenocarcinoma (TCGA): 3.89e-4
Lung Adenocarcinoma (TCGA): 5.42e-4
Colon Adenocarcinoma (TCGA): 9.06e-4
ETS2ETS proto-oncogene 2, transcription factor
Kidney Renal Clear Cell Carcinoma (validation): 3.37e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.11e-4
Colon Adenocarcinoma (TCGA): 9.47e-4
CABLES1Cdk5 and Abl enzyme substrate 1
Kidney Renal Clear Cell Carcinoma (TCGA): 4.14e-12
Glioblastoma Multiforme (validation): 2.12e-6
Kidney Renal Clear Cell Carcinoma (validation): 4.30e-5
Colon Adenocarcinoma (validation): 8.00e-4
MPZL2Myelin protein zero like 2
Kidney Renal Clear Cell Carcinoma (TCGA): 2.70e-10
Kidney Renal Clear Cell Carcinoma (validation): 1.44e-6
Pancreatic Adenocarcinoma (TCGA): 9.62e-5
Colon Adenocarcinoma (validation): 9.27e-4
KDSR3-ketodihydrosphingosine reductase
Kidney Renal Clear Cell Carcinoma (TCGA): 6.74e-10
Kidney Renal Clear Cell Carcinoma (validation): 1.35e-5
Colon Adenocarcinoma (validation): 8.75e-4
ATG14Autophagy related 14
Kidney Renal Clear Cell Carcinoma (TCGA): 4.67e-9
Colon Adenocarcinoma (validation): 1.09e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.73e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.98e-4
CPEB3Cytoplasmic polyadenylation element binding protein 3
Liver Hepatocellular Carcinoma (validation): 8.03e-9
Kidney Renal Clear Cell Carcinoma (TCGA): 8.20e-6
Liver Hepatocellular Carcinoma (TCGA): 3.40e-4
Glioblastoma Multiforme (validation): 4.16e-4
Colon Adenocarcinoma (validation): 4.96e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.05e-4
LIN54Lin-54 DREAM MuvB core complex component
Kidney Renal Clear Cell Carcinoma (TCGA): 1.84e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.28e-4
Lung Adenocarcinoma (TCGA): 1.52e-4
Colon Adenocarcinoma (validation): 6.98e-4
Page of 13 | next »